Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Commercial

The Rare Journey Needs a Special Pharmacy Partner

 March 27, 2026

Drug Channels

Today’s guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare.

CommercialRare DiseaseRead full story

Post navigation

Merck’s deal for Terns sparks debate over a possible biotech bidding war →
← Novartis targets Xolair successor in buyout of startup Excellergy

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com